Banggulan, Fritchel A.
HRN: 20-43-30 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/04/2022
CEFUROXIME 250MG/5ML, 50ML SUSPENSION (BOT)
07/04/2022
07/10/2022
PO
2ml
Bid
Uti
Waiting Final Action
Indication: Empiric Type of Infection: Urinary Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes